OSU6162
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for OSU6162, covering 2020-10-01 to 2025-03-24. Get the full timeline:
Most recent: Clinical Trial Update: OSU6162 as add-on in SSRI/SNRI-resistant Depression [Phase 2]